Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimuli‐Responsive PROTACs for Controlled Protein Degradation
Keli An, Xuqian Deng, Hongli Chi, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 39
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 18
BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy
Shiman Lu, Zhaoqing Shi, Chendi Ding, et al.
Biomaterials (2025) Vol. 317, pp. 123101-123101
Closed Access | Times Cited: 2
PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review
Chao Wang, Yujing Zhang, Wanpeng Yu, et al.
International Journal of Biological Macromolecules (2024) Vol. 261, pp. 129864-129864
Closed Access | Times Cited: 9
What influences the activity of Degrader−Antibody conjugates (DACs)
Yaolin Guo, Xiaoxue Li, Yang Xie, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116216-116216
Closed Access | Times Cited: 8
Stimuli-Responsive mRNA Vaccines to Induce Robust CD8+ T Cell Response via ROS-Mediated Innate Immunity Boosting
Linying Dong, Xuqian Deng, Yan Li, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 28, pp. 19218-19228
Closed Access | Times Cited: 8
Liposomal STAT3-Degrading PROTAC Prodrugs Promote Anti-Hepatocellular Carcinoma Immunity via Chemically Reprogramming Cancer Stem Cells
Xuan Wang, Youbo Zhao, Xin Li, et al.
Nano Letters (2024)
Closed Access | Times Cited: 6
Amphiphilic Affibody-PROTAC conjugate Self-Assembled nanoagents for targeted cancer therapy
Wenhui Gao, Xuelin Xia, Xiaoyuan Yang, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153437-153437
Closed Access | Times Cited: 5
A New target of ischemic ventricular arrhythmias—ITFG2
Qing-ming Pan, Fangfang Bi, Ze-hong Jing, et al.
European Journal of Pharmacology (2025), pp. 177301-177301
Closed Access
Mutually reinforced activatable NIR fluorescence/MR bimodal imaging enabled by tumor-specific biomarker amplification
Maolin Jiang, Ye Liu, Kewei Wang, et al.
(2025), pp. 100044-100044
Open Access
Cancer Specific CAIX‐Targeting Supramolecular Lysosome‐Targeting Chimeras (Supra‐LYTAC) for Targeted Protein Degradation
Do‐Hyun Kim, Gyeongseok Yang, Chaelyeong Lim, et al.
Advanced Science (2025)
Open Access
Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
Jiachan Lin, Zirui Chen, Dan Zhang, et al.
Macromolecular Rapid Communications (2025)
Closed Access
Stimulus-activated ribonuclease targeting chimeras for tumor microenvironment activated cancer therapy
Yuqi Zhang, Jinfeng Zhu, Ling Qiu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A Platform Approach to Cleavable Macrocycles for the Controlled Disassembly of Mechanically Caged Molecules
Abed Saady, Georgia K. Malcolm, Matthew P. Fitzpatrick, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 16
Open Access | Times Cited: 3
Securing LYTAC with Logic‐Identification System for Cancer Cell‐Selective Membrane Protein Degradation
Yanyun Fang, Yue Zhang, Shiyi Bi, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 3
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
Modular Development of Enzyme-Activatable Proteolysis Targeting Chimeras for Selective Protein Degradation and Cancer Targeting
Yanchi Chen, Lina Zhang, Lincheng Fang, et al.
JACS Au (2024) Vol. 4, Iss. 7, pp. 2564-2577
Open Access | Times Cited: 2
A photoactivatable upconverting nanodevice boosts the lysosomal escape of PROTAC degraders for enhanced combination therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 2
Controlled bioorthogonal activation of Bromodomain-containing protein 4 degrader by co-delivery of PROTAC and Pd-catalyst for tumor-specific therapy
Zhiyao Li, Tai‐Bai Jiang, Yuan Xu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 441-453
Closed Access | Times Cited: 2
Precise Modulation of Protein Degradation by Smart PROTACs
Junfei Cheng, Guoqiang Dong, Wei Wang, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 1
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
A Platform Approach to Cleavable Macrocycles for the Controlled Disassembly of Mechanically Caged Molecules
Abed Saady, Georgia K. Malcolm, Matthew P. Fitzpatrick, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 16
Open Access
Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation
Hanqiao Xu, Nobumichi Ohoka, Takao Inoué, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 107, pp. 129778-129778
Closed Access
Amphiphilic Affibody-Protac Conjugate Self-Assembled Nanoagents for Targeted Cancer Therapy
Wenhui Gao, Xuelin Xia, Xiaoyuan Yang, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top